Sun, 22-May-2022

Cancer Treatment

Gilead Sciences and Tango Therapeutics to Expand Str...

Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for patien... August 18, 2020 6:55 am By Neha Mule

Pharma and Biotech Companies Performing Strategic Ac...

Since past few years, global healthcare is consistently working on cancer treatments. Various common and rare cancer cases are being detected and this disease is killing patients due to unavailability of effic... August 14, 2020 2:37 pm By Neha Mule

Philips and BioIntelliSense form Strategic Collabora...

Royal Philips announced it has formed a strategic collaboration with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to integrate its BioSticker medical device into Philips... July 10, 2020 9:49 am By Neha Mule

Laser Therapy Enhances Treatments of Chronic Disease...

The concerns regarding of fitness and beauty among millennials have increased in recent years. Laser therapy or devices offer their clients/users a new level of precision and customisability. The availability ... July 3, 2020 10:43 am By Neha Mule

Merck’s KEYTRUDA (pembrolizumab) Approved in China...

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products Administration (NMPA) in China as monoth... June 22, 2020 10:50 am By Neha Mule

Innovent Announces the NMPA Granted Marketing Approv...

Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that BYVAS... June 19, 2020 11:31 am By Neha Mule

Calquence Showed Long-term Efficacy and Tolerability...

AstraZeneca announced detailed results from both the Phase II ACE-CL-001 trial and the pivotal Phase III ASCEND trial that showed the long-term efficacy and tolerability of Calquence (acalabrutinib) in chron... June 13, 2020 7:29 am By Neha Mule

1 2 3 4

Related News